News about Biotechnology, Pharmaceutical and Healthcare

03:28 EST 1st March 2015 | BioPortfolio

Latest news articles in the life-science, healthcare, medical device, biotechnology and pharmaceuticals sectors. 

Showing News Articles 1–25 of 6,900+

Saturday 28th February 2015

Global leader in ADC characterisation BioOutsource partners with Glythera

BioOutsource Ltd. (“BioOutsource”), a leading international Contract Testing Organization (CTO) has amplified its position as a global leader in Antibody Drug Conjugates (ADC) characterisation and are pleased to announce a partnership wit...

Friday 27th February 2015

Solid start for Animalcare

Veterinary products group Animalcare has today announced a “solid” start to its financial year, after pre-tax profits and revenue have both increased.The York-based group, which is made up of three product groups - licensed veterinary ...

Evocutis in deal with Venn Life Sciences

Skin research business Evocutis today agreed to sell its key intellectual property rights and assets to AIM-lists Venn Life Sciences.The deal, for £210,000, effectively sees Wetherby-based Evocutis sell all of its assets and it will become an...

Compliance Control moves into the BioHub at Alderley Park

Compliance Control have opened a virtual workspace at the BioHub at Alderley Park. The move will give us the opportunity to engage with the companies at the BioHub and help them with their Compliance and Quality requirements, as well as automate the...

Epic Pharma brings generic meperidine tablets and isradipine capsules to market

Michael JohnsenEpic Pharma on Friday launched two generics: a schedule II pain reliever and a calcium channel blocker.  read more

Dickinson's Original Witch Hazel introduces Daily Refreshingly Clean Cleansing Cloths

Michael JohnsenDickinson's Original Witch Hazel on Friday launched a gentle cleansing wipe solution.  read more

Bloomberg Intelligence reports 2015 will be strong year for biotech

Michael JohnsenRemedies for conditions like hepatitis C, NASH (nonalcoholic steatohepatitis) and oncology will all help contribute to growth within the biotech sector, according to an analysis from Bloomberg Intelligence. 

Christie Brinkley's new skin care line available in March

Antoinette AlexanderChristie Brinkley's new anti-aging skin care collection to help defend against Infrared damage. read more

New celebrity stylist-developed rotating curling iron offers greater styling versatility

Antoinette AlexanderFollowing the creation of the Beachwaver Pro rotating curling iron, celebrity hairstylist Sarah Potempa has introduced her latest innovation in hair styling. read more

Johnson & Johnson Health and Wellness Solutions to focus on wellness, prevention programs

Michael JohnsenJ&J formed Johnson & Johnson Health and Wellness Solutions to facilitate the development and implementation of programs that focus on wellness and prevention.  read more

Patients overwhelmingly recommend PharmaJet Needle-Free flu shot

Michael JohnsenNine-in-10 consumers who opted for a needle-free flu shot this season would choose that option again and recommend it to family and friends.  read more

New EU indication for Bayer and Regeneron eye drug

Bayer and Regeneron’s Eylea is now indicated for every type of the eye disease retinal vein occlusion (RVO) thanks to a new European Commission approval. Previously Eylea (aflibercept) had only been approved for macular edema (swelling in the eye) following central retinal vein occlusion (CRVO), but this new approval now includes the far more common branch retinal vein occlusion (BRVO). read mor...

Giant Eagle's Good Cents value grocer banner to close

Michael JohnsenGiant Eagle to close discount grocery concept Good Cents.  read more

New multipurpose Shave Butter launches at Rite Aid

Antoinette AlexanderVan der Hagen Enterprises launches its new all-in-one shaving cream and moisturizing after-balm at Rite Aid. read more

Drug candidate eCD4-Ig demonstrates durable protection against HIV infection

A drug candidate known as “eCD4-Ig” — a fusion of CD4-Ig with a small CCR5-mimetic sulfopeptide — has efficiently neutralised 100% of a diverse panel of HIV-1, HIV-2 and simian immunodeficiency virus isolates.

Viral cell entry holds clue to effective treatment of Ebola

Scientists have identified an important pathway used by the Ebola virus to gain entry into cells that may lead to new therapeutic approaches.

Creation of the new GSK, Novartis OTC JV expected for the first week of March

Michael JohnsenGlaxoSmithKline expects to complete its Novartis transaction in the week commencing March 2. read more

It's the 'perfect combination, perfect time' for Dove's latest treat

Ryan ChavisDove, a brand from Mars Chocolate North America, showed off its new line of Dove Fruit confections in New York City's Grand Central Terminal. read more

ACIP no longer makes preferential pediatric recommendation for nasal spray flu vaccine

Michael JohnsenACIP on Thursday recommended that children ages 6 months and older get an annual influenza vaccine with no preference stated for either the nasal spray vaccine or the flu shot. read more

Camber intros generic Revatio

Ryan ChavisCamber Pharmaceuticals' latest generic drug launch is used to treat pulmonary hypertension. read more

Ousted Sanofi boss finds role at PureTech

US science and technology R&D company PureTech has appointed the former Sanofi chief executive Christopher Viehbacher to its board. Viehbacher had been ejected from his role after the French firm’s board lost patience with his leadership style. He was replaced just last week by Bayer’s Olivier Brandicourt, whose role was filled by Werner Baumann. Image caption:  ...

Walgreens tells Vitamin Angels story in YouTube series

Michael JohnsenWalgreens and Vitamin Angels have generated enough funds to help more than 37.5 million children to date. read more

Walgreens showcases Vitamin Angels relationship with two new videos

Michael JohnsenWalgreens and Vitamin Angels have generated enough funds to help more than 37.5 million children to date. read more

Former RPS president Ian Caldwell dies

Source: Royal Pharmaceutical Society (RPS)  Ian Caldwell was RPS president in 1996–1997

Clear and concise information on drug interactions

‘Stockley’s drug interactions 2015 pocket companion’, edited by Claire L Preston.


Search BioPortfolio:
Loading
Advertisement
Advertisement